Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Corixa/GSK Will Submit Bexxar-Zevalin Trial Protocol To FDA In January

Dec 23 2002

• By The Pink Sheet

Related Content

Corixa, GSK Bulking Up Oncology Sales Forces In Preparation For Bexxar

Dec 23 2002

Idec Zevalin NHL Indication Split By Accelerated/Standard Approval

Feb 25 2002

Idec Zevalin Clears Cmte.: Non-Refractory Use May Be Accelerated Approval

Sep 17 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window